TA
CORZ icon

Trivest Advisors’s Core Scientific CORZ Stock Holding History

Trivest Advisors’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-365,500
Closed -$6.56M – 33
2025
Q3 		$6.56M Buy
+365,500
New +$5.36M 0.21% 29

Other funds holding CORZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $13.7B AUM 334.5% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $6.76B AUM 88.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $20.7B AUM 292.88% 1-Year Est. Return

Trivest Advisors's CORZ Position: Q4 2025 in Review

Trivest Advisors sold out of Core Scientific (CORZ) in Q4 2025, closing a stake of 365,500 shares — an estimated $6.56M sold.

Trivest Advisors first reported a position in CORZ in Q3 2025 and held it in 1 quarter. The position peaked at $6.56M in Q3 2025. 367 funds tracked by Wall St. Rank hold CORZ as of Q4 2025.

  • Trivest Advisors reported no remaining Core Scientific position as of Q4 2025 after selling out during the quarter.
  • Trivest Advisors sold 365,500 Core Scientific shares in Q4 2025, an estimated $6.56M.
  • Trivest Advisors first reported a position in Core Scientific in Q3 2025 and held it in 1 quarter.
  • Trivest Advisors's Core Scientific position peaked at $6.56M in Q3 2025.
  • 367 funds tracked by Wall St. Rank held Core Scientific as of Q4 2025.

Based on Trivest Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.